EpiWatch Closes Financing Round and Appoints New Directors
BALTIMORE, April 7, 2022 /PRNewswire/ -- EpiWatch, Inc., a digital health company focused on epilepsy, announced today the closing of its latest financing round and appointment of three new members to its Board of Directors.
- BALTIMORE, April 7, 2022 /PRNewswire/ -- EpiWatch, Inc., a digital health company focused on epilepsy, announced today the closing of its latest financing round and appointment of three new members to its Board of Directors.
- "We are pleased to have closed our latest financing round, adding talented and experienced experts to our Board of Directors.
- EpiWatch is initially developing a proprietary capability to detect and alert for potentially dangerous tonic-clonic (grand mal) seizures.
- EpiWatch is a registered trademark of the Johns Hopkins University in the United States and other countries.